Nano-X Imaging - NNOX Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $16.25
  • Forecasted Upside: 83.00%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$8.88
▼ -0.03 (-0.34%)

This chart shows the closing price for NNOX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Nano-X Imaging Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NNOX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NNOX

Analyst Price Target is $16.25
▲ +83.00% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Nano-X Imaging in the last 3 months. The average price target is $16.25, with a high forecast of $18.00 and a low forecast of $14.50. The average price target represents a 83.00% upside from the last price of $8.88.

This chart shows the closing price for NNOX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 2 contributing investment analysts is to buy stock in Nano-X Imaging. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/23/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/23/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/22/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/20/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/18/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/17/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/16/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/16/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/29/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$18.00 ➝ $18.00Low
2/15/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$18.00Low
1/19/2024Cantor FitzgeraldLower TargetOverweight ➝ Overweight$24.00 ➝ $18.00Low
11/29/2023Cantor FitzgeraldLower TargetOverweight ➝ Overweight$30.00 ➝ $24.00Low
10/3/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$30.00Low
9/26/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$30.00Low
9/8/2023Alliance Global PartnersInitiated CoverageBuy$14.50Low
8/18/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$30.00Low
5/24/2023Cantor FitzgeraldBoost Target$21.00 ➝ $30.00Low
1/5/2023Cantor FitzgeraldInitiated CoverageOverweight$21.00Low
11/17/2021Lifesci CapitalDowngradeOutperform ➝ Market PerformLow
6/3/2021Lifesci CapitalReiterated RatingOutperformHigh
4/26/2021LADENBURG THALM/SH SHInitiated CoverageBuy$52.00Low
4/19/2021LADENBURG THALM/SH SHInitiated CoverageBuyHigh
2/1/2021Cantor FitzgeraldLower TargetOverweight$70.00 ➝ $67.00Low
10/1/2020OppenheimerReiterated RatingHoldHigh
9/22/2020OppenheimerReiterated RatingHoldLow
9/15/2020Berenberg BankInitiated CoverageBuy$65.00High
9/15/2020OppenheimerInitiated CoverageMarket PerformHigh
9/15/2020Cantor FitzgeraldInitiated CoverageOverweight$70.00High
(Data available from 7/16/2019 forward)

News Sentiment Rating

0.39 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/19/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
1/18/2024
  • 5 very positive mentions
  • 11 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
2/17/2024
  • 9 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/18/2024
  • 6 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/17/2024
  • 1 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
5/17/2024
  • 3 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/16/2024
  • 3 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/16/2024

Current Sentiment

  • 3 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Nano-X Imaging logo
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.
Read More

Today's Range

Now: $8.88
Low: $8.72
High: $9.20

50 Day Range

MA: $8.18
Low: $6.52
High: $10.62

52 Week Range

Now: $8.88
Low: $4.89
High: $16.19

Volume

1,337,327 shs

Average Volume

2,383,304 shs

Market Capitalization

$513.08 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.04

Frequently Asked Questions

What sell-side analysts currently cover shares of Nano-X Imaging?

The following sell-side analysts have issued stock ratings on Nano-X Imaging in the last year: Alliance Global Partners, and Cantor Fitzgerald.
View the latest analyst ratings for NNOX.

What is the current price target for Nano-X Imaging?

2 Wall Street analysts have set twelve-month price targets for Nano-X Imaging in the last year. Their average twelve-month price target is $16.25, suggesting a possible upside of 83.0%. Cantor Fitzgerald has the highest price target set, predicting NNOX will reach $18.00 in the next twelve months. Alliance Global Partners has the lowest price target set, forecasting a price of $14.50 for Nano-X Imaging in the next year.
View the latest price targets for NNOX.

What is the current consensus analyst rating for Nano-X Imaging?

Nano-X Imaging currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe NNOX will outperform the market and that investors should add to their positions of Nano-X Imaging.
View the latest ratings for NNOX.

What other companies compete with Nano-X Imaging?

How do I contact Nano-X Imaging's investor relations team?

Nano-X Imaging's physical mailing address is COMMUNICATIONS CENTER, NEVE ILAN L3, 9085000. The company's listed phone number is 972-02-536-0360 and its investor relations email address is [email protected]. The official website for Nano-X Imaging is www.nanox.vision. Learn More about contacing Nano-X Imaging investor relations.